<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2405222059
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        1990
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        LIDOCAINE HCL EMERGENCY SYRINGE 2%
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        LIDOCAINE HYDROCHLORIDE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        2
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        %
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Intravenous use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Solution for injection
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        5
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        1
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Pre-filled syringe
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 25°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        21.45
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="HOSPIRA" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            HOSPIRA
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 2657]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Pfizer Saudi Trading
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            HOSPIRA INC
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        N01BB02
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Lidocaine Hydrochloride Injection belongs to groups of medicines known as local anaesthetics. Local anaesthetics stop pain and feeling in the area around where it is injected.</p><p>&nbsp;</p><p>Your doctor will be able to tell you about the specific condition for which you have been prescribed Lidocaine Hydrochloride Injection.</p><p>&nbsp;</p><p>This medicine is available only with a doctor&#39;s prescription.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Lidocaine Hydrochloride Injection should not be used</strong></p><p><strong>&nbsp;</strong></p><p>If you have an allergy to lidocaine or any of the ingredients listed at the end of this leaflet.&nbsp; Symptoms of an allergic reaction may include shortness of breath, wheezing or difficulty breathing, swelling of the face, lips, tongue or other parts of the body, rash, itching or hives on the skin.</p><p>&nbsp;</p><p><strong>Warnings and precautions</strong></p><p><strong>&nbsp;</strong></p><p><strong>Special care needs to be taken with </strong><strong>Lidocaine Hydrochloride Injection</strong></p><p><strong>&nbsp;</strong></p><p>You have any allergies to:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; any other medicine</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; any other substances, such as foods, preservatives or dyes</p><p>&nbsp;</p><p>You have or have had any medical conditions, especially the following:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; liver and/or kidney problems</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; epilepsy and porphyria</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; diseases of the brain and spinal cord</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; heart problems</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; severe fever</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; problems with your blood pressure or circulation</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; slow heart beat</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; low potassium level</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; breathing difficulties</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; low oxygen in blood</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; problems with the clotting of your blood</p><p>&nbsp;</p><p>If possible, tell your doctor if you think any of the above applies to you before this medicine is used.</p><p>&nbsp;</p><p><strong>Children</strong></p><p>The dose of this medicine should be reduced in children</p><p>&nbsp;</p><p><strong>Other medicines and Lidocaine Hydrochloride Injection</strong></p><p>Tell your doctor, pharmacist or nurse if you are taking, have recently taken or might take any other medicines, including medicines obtained without a prescription.</p><p><strong>&nbsp;</strong></p><p>Special care is needed if you are taking/using other medicines as some could interact with Lidocaine Hydrochloride. For example:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; monoamine oxidase inhibitors or tricyclic anti-depressants</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Phenothiazines and butyrophenones</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; vasopressor drugs</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ergot-type oxytocic drugs</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; medicines to control fits or epilepsy, e.g. phenytoin, carbamazepine, primidone, phenobarbitone, sodium valproate</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; some anaesthetics</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; nitrates/nitrites e.g. nitric oxide, nitroglycerin, sodium nitroprusside, nitrous oxide</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; antineoplastic agents e.g. cyclophosphamide monohydrate, flutamide, hydroxyurea, ifosfamide, rasburicase</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; some antibiotics</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; antimalarials e.g. chloroquine phosphate, primaquine</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; other drugs such as acetaminophen, metoclopromaide, quinine, sulfasalazine</p><p>&nbsp;</p><p>Your doctor will have more information on medicines to be careful with or avoid while you are being given Lidocaine Hydrochloride Injection. Your doctor will advise you about continuing to take other medicines while you are receiving Lidocaine Hydrochloride Injection.</p><p>&nbsp;</p><p><strong>Pregnancy, breast-feeding and fertility</strong></p><p>If you are pregnant, or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor, pharmacist or nurse for advice before taking this medicine. Your doctor will only use this medicine if the expected benefits outweigh any potential risk to your baby.</p><p>&nbsp;</p><p><u>Pregnancy</u></p><p>If you are pregnant you should talk to your doctor or pharmacist before taking this medicine</p><p>&nbsp;</p><p><u>Breast-feeding</u></p><p>It is not known whether this drug is excreted in human milk. If you are breast‑feeding, caution should be exercised when Lidocaine Hydrochloride Injection is administered.</p><p>&nbsp;</p><p><strong>Driving and using machines</strong></p><p>Be careful driving or operating machinery after you have been given Lidocaine Hydrochloride Injection. You may be drowsy or your reflexes may be slow. (see also section 4 Possible side effects)</p><p>&nbsp;</p><p>Do not drink alcohol while you are being given Lidocaine Hydrochloride Injection. If you drink alcohol while you are being given Lidocaine Hydrochloride Injection, your blood pressure may drop making you feel dizzy and faint.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Lidocaine Hydrochloride Injection is given by injection into the skin, directly into the blood stream or into an organ. It must only be given by a doctor or nurse.</p><p>&nbsp;</p><p>Your doctor will decide what dose and how long you will receive Lidocaine Hydrochloride Injection.</p><p>&nbsp;</p><p><strong>If you are given too much Lidocaine Hydrochloride Injection</strong></p><p>This rarely happens as Lidocaine Hydrochloride Injection is administered under the care of a highly trained doctor.</p><p>&nbsp;</p><p>However, if you are given too much Lidocaine Hydrochloride Injection, you may experience some of the side effects listed below (see section 4 Possible side effects).</p><p>&nbsp;</p><p>Your doctor has information on how to recognise and treat an overdose. Ask your doctor if you have any concerns.</p><p><strong>&nbsp;</strong></p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Tell your doctor, nurse or pharmacist as soon as possible if you do not feel well while you are being given Lidocaine Hydrochloride Injection.</strong></p><p>&nbsp;</p><p>Like other medicines, lidocaine can cause some side effects. If they occur, most are likely to be minor or temporary. However, some may be serious and need medical attention.</p><p>&nbsp;</p><p>Tell your doctor or nurse if you notice any of the following:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; weakness, confusion, nervousness, agitation, drowsiness, disorientation or unconsciousness</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; nausea, vomiting, difficulty in swallowing</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; headache, dizziness or light-headedness especially if you get up suddenly from a lying or sitting position</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; ringing in the ears</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; slurred speech, sensations of heat and cold</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; numbness, tremors, twitching</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; slow heart beat, low blood pressure</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; breathing difficulties</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; blurred or double vision</p><p>&nbsp;</p><p>These are the mild side effects of Lidocaine Hydrochloride Injection.</p><p>&nbsp;</p><p>Serious side effects of Lidocaine Hydrochloride Injection include:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; fits or convulsions</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; skin rash, hives or itching</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; unconsciousness</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; breathing problems</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; low blood pressure</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; slow heart beat</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; collapse</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; pale, grey, or blue coloured skin (cyanosis)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; rapid heart rate</p><p>&nbsp;</p><p>You may need urgent medical attention if you get these side effects.</p><p>&nbsp;</p><p>Other side effects not listed above may also occur in some patients. If you notice any other effects, check with your doctor.&nbsp; Some side effects may only be seen by your doctor.</p><p>&nbsp;</p><p><strong><u>Reporting of side effects</u></strong></p><p>If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. By reporting side effects you can help provide more information on the safety of this medicine.</p><p>&nbsp;</p><p>To Report side effects:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Saudi Arabia</strong></p><p>&nbsp;</p><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>National Pharmacovigilance Centre (NPC)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; SFDA Call Center: 19999</p><ul><li>E-mail: npc.drug@sfda.gov.sa</li><li>Website: https://ade.sfda.gov.sa/&nbsp;&nbsp;</li></ul></td></tr></tbody></table><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Other GCC States</strong></p><p><strong>&nbsp;</strong></p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Please contact the relevant competent authority.</p></td></tr></tbody></table><p><u>&nbsp;</u></p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Keep this medicine out of the sight and reach of children.</p><p>&nbsp;</p><p><strong>Expiry</strong></p><p>This medicine must not be used after the expiry date which is stated on the ampoule label and carton after &#39;EXP&#39;. Where only a month and year is stated, the expiry date refers to the last day of that month.</p><p>&nbsp;</p><p><strong>Storage </strong></p><p>Store 20 to 25&deg;C. Keep the pre-filled syringe in the outer carton in order to protect from light.</p><p>&nbsp;</p><p>For single use. Discard any unused contents</p><p>&nbsp;</p><p><strong>Visible signs of deterioration</strong></p><p>Do not use unless the solution is clear.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The active substance is Lidocaine hydrochloride. Each millilitre (ml) of solution contains 10 milligrams (mg) of Lidocaine hydrochloride or 20 milligrams (mg) of Lidocaine hydrochloride.</p><p>&nbsp;</p><p>The other ingredients are sodium chloride and water for injections.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Lidocaine Hydrochloride Injection is a clear, practically colourless solution for injection  which comes in pre-filled syringe. 
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Marketing Authorization Holder:</strong></p><p>Hospira Inc, 275 North Field Drive, Lake Forest, IL 60045, United States</p><p>&nbsp;</p><p><strong>Manufacturer:</strong></p><p>Hospira Inc, Highway 301 North, Rocky Mount, NC 27801, United States</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                July 2021.
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL">&nbsp;تنتمي حقن ليدوكايين هيدروكلوريد إلى مجموعة من الأدوية تعرف باسم المخدرات الموضعية. فهي توقف الألم والإحساس في المنطقة المحيطة بمكان حقنها.</p><p>&nbsp;</p><p dir="RTL">سيكون طبيبك قادرًا على إخبارك عن الحالة المحددة التي من أجلها وُصفت لك حقن ليدوكايين هيدروكلوريد.</p><p>&nbsp;</p><p dir="RTL">هذا الدواء متاح فقط بوصفة طبيب.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>موانع استعمال حقن ليدوكايين هيدروكلوريد</strong></p><p><strong>&nbsp;</strong></p><p dir="RTL">إذا كنت تعاني من حساسية تجاه ليدوكايين أو أي من المكونات المذكورة في نهاية هذه النشرة.&nbsp; قد تتضمن أعراض تفاعل الحساسية ضيق التنفس، أو الأزيز، أو صعوبة التنفس، أو تورم الوجه أو الشفتين أو اللسان أو أجزاء أخرى من الجسم، أو الطفح الجلدي، أو الحكة، أو الشرى على الجلد.</p><p>&nbsp;</p><p dir="RTL"><strong>الاحتياطات عند استعمال حقن ليدوكايين هيدروكلوريد</strong></p><p>&nbsp;</p><p dir="RTL"><strong>يلزم توخي الحذر بشكل خاص مع حقن ليدوكايين هيدروكلوريد</strong></p><p>&nbsp;</p><p dir="RTL">إذا كان لديك أي حساسية تجاه:</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;أي دواء آخر</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أي مواد أخرى مثل الأطعمة، أو المواد الحافظة، أو الأصباغ</p><p>&nbsp;</p><p dir="RTL">إذا كنت تعاني أو سبق لك أن عانيت من أي حالات طبية، خاصة ما يلي:</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مشكلات في الكبد و/أو الكلى</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الصرع والبرفيرية</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أمراض الدماغ والحبل الشوكي</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مشكلات القلب</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الحمى الشديدة</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مشكلات في ضغط الدم أو الدورة الدموية</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; بطء ضربات القلب</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انخفاض مستوى البوتاسيوم</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; صعوبات في التنفس</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انخفاض نسبة الأكسجين في الدم</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مشكلات في تخثر الدم</p><p>&nbsp;</p><p dir="RTL">إن أمكن، فأخبر طبيبك إذا كنت تعتقد أن أيًا من الحالات المذكورة أعلاه تنطبق عليك قبل استخدام هذا الدواء.</p><p>&nbsp;</p><p dir="RTL"><strong>الأطفال</strong></p><p dir="RTL">&nbsp;ينبغي خفض جرعة هذا الدواء عند الاستخدام مع الأطفال</p><p>&nbsp;</p><p dir="RTL"><strong>&nbsp;التداخلات الدوائية مع أخذ هذا المستحضر مع أي أدوية أخرى أو أعشاب أو مكملات غذائية</strong></p><p dir="RTL">أخبر طبيبك أو الصيدلي أو الممرضة إذا كنت تتناول أو تناولت مؤخرًا أو قد تتناول أي أدوية أخرى، بما في ذلك الأدوية التي يتم الحصول عليها دون وصفة طبية.</p><p><strong>&nbsp;</strong></p><p dir="RTL">يلزم توخي الحذر بشكل خاص إذا كنت تتناول/تستخدم أدوية أخرى، لأن بعضها قد يتفاعل مع ليدوكايين هيدروكلوريد. على سبيل المثال:</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مثبطات أوكسيداز أحادي الأمين أو مضادات الاكتئاب ثلاثية الحلقات</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الفينوثيازينات والبوتيروفينونات</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; العقاقير المضيقة للأوعية</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; العقاقير المحفزة للولادة من نوع الإرجوت</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الأدوية المستخدمة للسيطرة على النوبات أو الصرع، مثل فينيتوين، كاربامازيبين، بريميدون، فينوباربيتون، فالبروات الصوديوم</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; بعض أدوية التخدير</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; النترات/النيتريتات مثل أكسيد النيتريك، نتروجليسرين، نتروبروسيد الصوديوم، أكسيد النيتروز</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; العوامل المضادة للأورام مثل سيكلوفوسفاميد أحادي الهيدرات، فلوتاميد، هيدروكسي يوريا، إيفوسفاميد، راسبوريكاز</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; بعض المضادات الحيوية</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مضادات الملاريا مثل فوسفات الكلوروكين، بريماكين</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أدوية أخرى مثل اسيتامينوفين، ميتوكلوبراميد، كينين، سلفاسالازين</p><p>&nbsp;</p><p dir="RTL">سيكون لدى طبيبك المزيد من المعلومات حول الأدوية التي ينبغي توخي الحذر عند استخدامها أو تجنبها أثناء تلقيك لحقن ليدوكايين هيدروكلوريد. وسينصحك طبيبك بالاستمرار في تناول الأدوية الأخرى أثناء تلقيك حقن ليدوكايين هيدروكلوريد.</p><p>&nbsp;</p><p dir="RTL"><strong>الحمل والرضاعة</strong></p><p dir="RTL">إذا كنتِ حاملًا أو ترضعين رضاعة طبيعية أو تعتقدين أنكِ ربما تكونين حاملًا أو تخططين للحمل، فاطلبي من طبيبكِ أو الصيدلي أو الممرضة المشورة قبل تلقي هذا الدواء. سيستخدم طبيبكِ هذا الدواء فقط إذا كانت الفوائد المتوقعة تفوق أي مخاطر محتملة على طفلكِ.</p><p>&nbsp;</p><p dir="RTL"><u>الحمل</u></p><p dir="RTL">إذا كنتِ حاملًا، ينبغي لكِ التحدث مع طبيبكِ أو الصيدلي قبل تلقي هذا الدواء</p><p>&nbsp;</p><p dir="RTL"><u>الرضاعة</u></p><p dir="RTL">ليس معروفًا ما إذا كان يتم إفراز هذا العقار في لبن الأم أم لا. إذا كنتِ تُرضعين رضاعة طبيعية، ينبغي توخي الحذر عند تلقي حقن ليدوكايين هيدروكلوريد.</p><p>&nbsp;</p><p dir="RTL"><strong>تأثير حقن ليدوكايين هيدروكلوريد على القيادة واستخدام الآلات</strong></p><p dir="RTL">كن حذرًا عند القيادة أو تشغيل الآلات بعد أن يتم إعطاؤك حقن ليدوكايين هيدروكلوريد. فقد تشعر بالنعاس أو قد تكون ردود أفعالك بطيئة. (انظر أيضًا القسم ٤ &quot;الأعراض الجانبية&quot;)</p><p>&nbsp;</p><p dir="RTL">لا تتناول الكحول أثناء تلقيك حقن ليدوكايين هيدروكلوريد. إذا تناولت الكحول أثناء تلقيك حقن ليدوكايين هيدروكلوريد، فقد ينخفض ضغط دمك مما يجعلك تشعر بالدوار والإغماء.</p><p>&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">يتم إعطاء حقن ليدوكايين هيدروكلوريد عن طريق الحقن في الجلد أو في مجرى الدم مباشرة أو في أحد الأعضاء. ويجب أن يقوم طبيب أو ممرضة فقط بإعطائه.</p><p>&nbsp;</p><p dir="RTL">سيقرر طبيبك الجرعة والمدة الزمنية التي ستتلقى فيها حقن ليدوكايين هيدروكلوريد.</p><p>&nbsp;</p><p dir="RTL"><strong>الجرعة الزائدة من حقن ليدوكايين هيدروكلوريد</strong></p><p dir="RTL">نادرًا ما يحدث هذا الأمر لأن حقن ليدوكايين هيدروكلوريد يتم إعطاؤها تحت رعاية طبيب على درجة عالية من التدريب.</p><p>&nbsp;</p><p dir="RTL">ومع ذلك، إذا تلقيت جرعة زائدة من حقن ليدوكايين هيدروكلوريد، فقد تواجه بعض الأعراض الجانبية المذكورة أدناه (انظر القسم ٤ &quot;الأعراض الجانبية&quot;).</p><p>&nbsp;</p><p dir="RTL">لدى طبيبك معلومات حول كيفية التعرف على علامات الجرعة الزائدة وعلاج آثارها. اسأل طبيبك إذا كان لديك أي مخاوف.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>&nbsp;أخبر طبيبك أو الممرضة أو الصيدلي في أقرب وقت ممكن إذا كنت لا تشعر بصحة جيدة أثناء تلقيك حقن ليدوكايين هيدروكلوريد.</strong></p><p>&nbsp;</p><p dir="RTL">مثل الأدوية الأخرى، يمكن أن تُسبب حقن ليدوكايين هيدروكلوريد بعض الأعراض الجانبية. إذا حدثت، فمن المرجح أن يكون معظمها طفيفًا أو مؤقتًا. ومع ذلك، قد يكون بعضها خطيرًا ويحتاج إلى رعاية طبية.</p><p>&nbsp;</p><p dir="RTL">أخبر طبيبك أو ممرضتك إذا لاحظت أيًا مما يلي:</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;الضعف، أو الارتباك، أو التوتر، أو التهيج، أو النعاس، أو التوهان، أو فقدان الوعي</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; الغثيان، القيء، صعوبة في البلع</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; الصداع، أو الدوار، أو الدوخة خاصة إذا قمت فجأة من وضعية الاستلقاء أو الجلوس</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; طنين في الأذنين</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; تداخل الكلام، إحساس بالحرارة والبرودة</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; الخدر، الرعاش، الارتجاف</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; بطء ضربات القلب، ضغط الدم المنخفض</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; صعوبات في التنفس</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; تغيم أو ازدواج الرؤية</p><p>&nbsp;</p><p dir="RTL">هذه هي الأعراض الجانبية الخفيفة لحقن ليدوكايين هيدروكلوريد.</p><p>&nbsp;</p><p dir="RTL">تتضمن الأعراض الجانبية الخطيرة لحقن ليدوكايين هيدروكلوريد ما يلي:</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; النوبات أو التشنجات</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; الطفح الجلدي أو الشرى أو الحكة</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; فقدان الوعي</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; مشكلات في التنفس</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; ضغط الدم المنخفض</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; بطء ضربات القلب</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; الهبوط</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; شحوب الجلد أو الجلد رمادي أو أزرق اللون (الازرقاق)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; سرعة معدل نبضات القلب</p><p>&nbsp;</p><p dir="RTL">قد تحتاج إلى رعاية طبية عاجلة إذا تعرضت لهذه الأعراض الجانبية.</p><p>&nbsp;</p><p dir="RTL">قد تحدث أعراض جانبية أخرى غير مذكورة أعلاه لدى بعض المرضى. إذا لاحظت أي أعراض جانبية أخرى، فاستشر طبيبك.&nbsp; فبعض الأعراض الجانبية قد لا يكتشفها إلا طبيبك.</p><p>&nbsp;</p><p dir="RTL"><strong><u>الإبلاغ عن الأعراض الجانبية</u></strong></p><p dir="RTL">إذا أصبت بأي أعراض جانبية، فتحدث إلى طبيبك أو الصيدلي أو الممرضة. يتضمن هذا أي أعراض جانبية محتملة غير مذكورة في هذه النشرة. بالإبلاغ عن الأعراض الجانبية، يمكنك المساعدة في توفير المزيد من المعلومات حول سلامة هذا الدواء.</p><p>&nbsp;</p><p dir="RTL">للإبلاغ عن الأعراض الجانبية:</p><p dir="RTL"><strong><em>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em></strong><strong>المملكة العربية السعودية</strong></p><p>&nbsp;</p><table dir="rtl" border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p dir="RTL">المركز الوطني للتيقظ الدوائي</p><p dir="RTL"><em>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em>مركز الاتصال الموحد: ۱۹۹۹۹</p><ul><li dir="RTL">البريد الإلكتروني: npc.drug@sfda.gov.sa</li><li dir="RTL">الموقع الإلكتروني: https://ade.sfda.gov.sa/&nbsp;&nbsp;</li></ul></td></tr></tbody></table><p>&nbsp;</p><p dir="RTL"><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>دول الخليج الأخرى</strong></p><p><strong>&nbsp;</strong></p><table dir="rtl" border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p dir="RTL"><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong>الرجاء الاتصال بالمؤسسات والهيئات الوطنية في كل دولة.</p></td></tr></tbody></table>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">احفظ هذا الدواء بعيدًا عن مرأى ومتناول الأطفال.</p><p>&nbsp;</p><p dir="RTL"><strong>انتهاء الصلاحية</strong></p><p dir="RTL">يجب عدم استخدام هذا الدواء بعد تاريخ انتهاء الصلاحية المدون على ملصق الأمبولة والعبوة الكرتونية بعد الرمز &quot;EXP&quot;. في حالة ذكر الشهر والعام فقط، فإن تاريخ انتهاء الصلاحية يشير إلى آخر يوم من الشهر المذكور.</p><p>&nbsp;</p><p dir="RTL"><strong>التخزين</strong></p><p dir="RTL">&nbsp;يُخزن في درجة حرارة تتراوح بين ۲۰ و۲٥ درجة مئوية. احتفظ بالمحقنة مسبقة التعبئة في العبوة الكرتونية الخارجية من أجل حمايتها من الضوء.</p><p>&nbsp;</p><p dir="RTL">مخصص للاستخدام مرة واحدة. تخلص من أي محتويات غير مستخدمة</p><p>&nbsp;</p><p dir="RTL"><strong>علامات التلف الظاهرة</strong></p><p dir="RTL">لا تستخدمه إلا إذا كان المحلول صافيًا.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">المادة الفعالة هي ليدوكايين هيدروكلوريد. يحتوي كل ملليلتر (مل) واحد من المحلول على ۱۰ مليجرام (ملجم) من ليدوكايين هيدروكلوريد أو ۲۰مليجرام (ملجم) من ليدوكايين هيدروكلوريد.</p><p>&nbsp;</p><p dir="RTL">المكونات الأخرى هي كلوريد الصوديوم وماء للحقن.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>حقن ليدوكايين هيدروكلوريد</strong> هي محلول صافٍ عديم اللون تقريبًا مخصص للحقن يأتي في محقنة مسبقة التعبئة.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>مالك رخصة التسويق</strong></p><p>Hospira Inc, 275 North Field Drive, Lake Forest, IL 60045, United States</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>المصنع</strong></p><p dir="RTL">Hospira Inc, Highway 301 North, Rocky Mount, NC 27801, United States</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            	يوليو/تموز ۲۰۲۱.
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Lidocaine Hydrochloride 10 mg/ml solution for injection
Lidocaine Hydrochloride 20 mg/ml solution for injection 

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Lidocaine Hydrochloride Injection, USP is a sterile, nonpyrogenic solution of lidocaine hydrochloride in water for injection for parenteral administration in various concentrations with characteristics as follows:

Concentration	1%	2%
mg/ml lidocaine HCl (anhyd.)	10	20
mg/ml sodium chloride	7	6

Lidocaine is a local anesthetic of the amide type.

Lidocaine Hydrochloride, USP is chemically designated 2-(diethylamino)-N-(2,6-dimethylphenyl) -acetamide monohydrochloride monohydrate, a white powder freely soluble in water. The molecular weight is 288.82. It has the following structural formula:
 

For the full list of excipients, see section 6.1 List of excipients.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Solution for injection.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Lidocaine Hydrochloride Injection, USP is indicated for production of local or regional anesthesia by infiltration techniques such as percutaneous injection and intravenous regional anesthesia by peripheral nerve block techniques such as brachial plexus and intercostal and by central neural techniques such as lumbar and caudal epidural blocks, when the accepted procedures for these techniques as described in standard textbooks are observed.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Posology</u></p><p>&nbsp;</p><p>Table 1 (Recommended Dosages) summarizes the recommended volumes and concentrations of Lidocaine Hydrochloride Injection, USP for various types of anesthetic procedures. The dosages suggested in this table are for normal healthy adults and refer to the use of epinephrine-free solutions. When larger volumes are required, only solutions containing epinephrine should be used except in those cases where vasopressor drugs may be contraindicated.</p><p>There have been adverse event reports of chondrolysis in patients receiving intra-articular infusions of local anesthetics following arthroscopic and other surgical procedures. Lidocaine is not approved for this use (see section <em>4.4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Special warnings and precautions for use</em>).</p><p>These recommended doses serve only as a guide to the amount of anesthetic required for most routine procedures. The actual volumes and concentrations to be used depend on a number of factors such as type and extent of surgical procedure, depth of anesthesia and degree of muscular relaxation required, duration of anesthesia required, and the physical condition of the patient. In all cases the lowest concentration and smallest dose that will produce the desired result should be given. Dosages should be reduced for children and for the elderly and debilitated patients and patients with cardiac and/or liver disease.</p><p>The onset of anesthesia, the duration of anesthesia and the degree of muscular relaxation are proportional to the volume and concentration (i.e., total dose) of local anesthetic used. Thus, an increase in volume and concentration of Lidocaine Hydrochloride Injection will decrease the onset of anesthesia, prolong the duration of anesthesia, provide a greater degree of muscular relaxation and increase the segmental spread of anesthesia. However, increasing the volume and concentration of Lidocaine Hydrochloride Injection may result in a more profound fall in blood pressure when used in epidural anesthesia. Although the incidence of side effects with lidocaine HCl is quite low, caution should be exercised when employing large volumes and concentrations, since the incidence of side effects is directly proportional to the total dose of local anesthetic agent injected.</p><p><strong>&nbsp;</strong></p><p><strong>Epidural Anesthesia</strong></p><p>Although Lidocaine Hydrochloride solutions are intended specifically for epidural anesthesia, they may also be used for infiltration and peripheral nerve block, provided they are employed as single dose units. These solutions contain no bacteriostatic agent.</p><p>In epidural anesthesia, the dosage varies with the number of dermatomes to be anesthetized (generally 2&nbsp;to 3 ml of the indicated concentration per dermatome).</p><p><strong>&nbsp;</strong></p><p><strong>Caudal and Lumbar Epidural Block</strong></p><p>As a precaution against the adverse experience sometimes observed following unintentional penetration of the subarachnoid space, a test dose such as 2 to 3 ml of 1.5% lidocaine HCl should be administered at least 5 minutes prior to injecting the total volume required for a lumbar or caudal epidural block. The test dose should be repeated if the patient is moved in a manner that may have displaced the catheter. Epinephrine, if contained in the test dose (10 to 15 mcg have been suggested), may serve as a warning of unintentional intravascular injection. If injected into a blood vessel, this amount of epinephrine is likely to produce a transient &ldquo;epinephrine response&rdquo; within 45&nbsp;seconds, consisting of an increase in heart rate and systolic blood pressure, circumoral pallor, palpitations and nervousness in the unsedated patient. The sedated patient may exhibit only a pulse rate increase of 20 or more beats per minute for 15 or more seconds. Patients on beta-blockers may not manifest changes in heart rate, but blood pressure monitoring can detect an evanescent rise in systolic blood pressure. Adequate time should be allowed for onset of anesthesia after administration of each test dose. The rapid injection of a large volume of Lidocaine Hydrochloride Injection through the catheter should be avoided, and, when feasible, fractional doses should be administered.</p><p>In the event of the known injection of a large volume of local anesthetic solution into the subarachnoid space, after suitable resuscitation and if the catheter is in place, consider attempting the recovery of drug by draining a moderate amount of cerebrospinal fluid (such as 10 ml) through the epidural catheter.</p><p><strong>Maximum Recommended Dosages</strong></p><p><strong>NOTE: The products accompanying this insert do not contain epinephrine.</strong></p><p><strong>Adults</strong></p><p>For normal healthy adults, the individual maximum recommended dose of lidocaine HCl with epinephrine should not exceed 7 mg/kg (3.5 mg/lb) of body weight, and in general it is recommended that the maximum total dose not exceed 500 mg. When used without epinephrine the maximum individual dose should not exceed 4.5 mg/kg (2 mg/lb) of body weight, and in general it is recommended that the maximum total dose does not exceed 300 mg. For continuous epidural or caudal anesthesia, the maximum recommended dosage should not be administered at intervals of less than 90 minutes. When continuous lumbar or caudal epidural anesthesia is used for non-obstetrical procedures, more drug may be administered if required to produce adequate anesthesia.</p><p>The maximum recommended dose per 90 minute period of lidocaine hydrochloride for paracervical block in obstetrical patients and non-obstetrical patients is 200 mg total. One-half of the total dose is usually administered to each side. Inject slowly, five minutes between sides (see also discussion of paracervical block in section <em>4.4 Special warnings and precautions for use</em>).</p><p>For intravenous regional anesthesia, the dose administered should not exceed 4 mg/kg in adults.</p><p><strong>Children</strong></p><p>It is difficult to recommend a maximum dose of any drug for children, since this varies as a function of age and weight. For children over 3 years of age who have a normal lean body mass and normal body development, the maximum dose is determined by the child&rsquo;s age and weight. For example, in a child of 5&nbsp;years weighing 50 lbs the dose of lidocaine HCl should not exceed 75 to 100 mg (1.5&nbsp;to&nbsp;2&nbsp;mg/lb). The use of even more dilute solutions (i.e., 0.25 to 0.5%) and total dosages not to exceed 3&nbsp;mg/kg (1.4 mg/lb) are recommended for induction of intravenous regional anesthesia in children.</p><p>In order to guard against systemic toxicity, the lowest effective concentration and lowest effective dose should be used at all times. In some cases it will be necessary to dilute available concentrations with 0.9% sodium chloride injection in order to obtain the required final concentration.</p><p><strong>NOTE: </strong>Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration whenever the solution and container permit. Solutions that are discolored and/or contain particulate matter should not be used.</p><p><strong>&nbsp;</strong></p><p><strong>Table 1</strong>&nbsp;&nbsp; <strong>Recommended Dosages</strong></p><p><strong>&nbsp;</strong></p><table border="1" cellspacing="0" cellpadding="0" style="width:94%"><tbody><tr><td rowspan="2" style="vertical-align:bottom"><p><strong>Procedure</strong></p></td><td colspan="3" style="vertical-align:top"><p><strong>Lidocaine Hydrochloride</strong></p><p><strong>Injection, USP</strong></p><p><strong>(without Epinephrine)</strong></p></td></tr><tr><td><p><strong>Conc. (%)</strong></p></td><td><p><strong>Vol. (ml)</strong></p></td><td><p><strong>Total Dose (mg)</strong></p></td></tr><tr><td style="vertical-align:top"><p><strong>Infiltration</strong></p></td><td style="vertical-align:bottom"><p><strong>&nbsp;</strong></p></td><td style="vertical-align:bottom"><p><strong>&nbsp;</strong></p></td><td style="vertical-align:bottom"><p><strong>&nbsp;</strong></p></td></tr><tr><td style="vertical-align:top"><p>Percutaneous</p></td><td style="vertical-align:bottom"><p>0.5 or 1</p></td><td style="vertical-align:bottom"><p>1 to 60</p></td><td style="vertical-align:bottom"><p>5 to 300</p></td></tr><tr><td style="vertical-align:top"><p>Intravenous regional</p></td><td style="vertical-align:bottom"><p>0.5</p></td><td style="vertical-align:bottom"><p>10 to 60</p></td><td style="vertical-align:bottom"><p>50 to 300</p></td></tr><tr><td style="vertical-align:top"><p><strong>Peripheral Nerve Blocks, e.g.</strong></p></td><td style="vertical-align:bottom"><p>&nbsp;</p></td><td style="vertical-align:bottom"><p>&nbsp;</p></td><td style="vertical-align:bottom"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p>Brachial</p></td><td style="vertical-align:bottom"><p>1.5</p></td><td style="vertical-align:bottom"><p>15 to 20</p></td><td style="vertical-align:bottom"><p>225 to 300</p></td></tr><tr><td style="vertical-align:top"><p>Dental</p></td><td style="vertical-align:bottom"><p>2</p></td><td style="vertical-align:bottom"><p>1 to 5</p></td><td style="vertical-align:bottom"><p>20 to 100</p></td></tr><tr><td style="vertical-align:top"><p>Intercostal</p></td><td style="vertical-align:bottom"><p>1</p></td><td style="vertical-align:bottom"><p>3</p></td><td style="vertical-align:bottom"><p>30</p></td></tr><tr><td style="vertical-align:top"><p>Paravertebral</p></td><td style="vertical-align:bottom"><p>1</p></td><td style="vertical-align:bottom"><p>3 to 5</p></td><td style="vertical-align:bottom"><p>30 to 50</p></td></tr><tr><td style="vertical-align:top"><p>Pudendal (each side)</p></td><td style="vertical-align:bottom"><p>1</p></td><td style="vertical-align:bottom"><p>10</p></td><td style="vertical-align:bottom"><p>100</p></td></tr><tr><td style="vertical-align:top"><p><strong>Paracervical</strong></p></td><td style="vertical-align:bottom"><p>&nbsp;</p></td><td style="vertical-align:bottom"><p>&nbsp;</p></td><td style="vertical-align:bottom"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p>Obstetrical analgesia (each side)</p></td><td style="vertical-align:bottom"><p>1</p></td><td style="vertical-align:bottom"><p>10</p></td><td style="vertical-align:bottom"><p>100</p></td></tr><tr><td style="vertical-align:top"><p><strong>Sympathetic Nerve Blocks, e.g.</strong></p></td><td style="vertical-align:bottom"><p>&nbsp;</p></td><td style="vertical-align:bottom"><p>&nbsp;</p></td><td style="vertical-align:bottom"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p>Cervical</p><p>(stellate ganglion)</p></td><td style="vertical-align:top"><p>1</p></td><td style="vertical-align:top"><p>5</p></td><td style="vertical-align:top"><p>50</p></td></tr><tr><td style="vertical-align:top"><p>Lumbar</p></td><td style="vertical-align:bottom"><p>1</p></td><td style="vertical-align:bottom"><p>5 to 10</p></td><td style="vertical-align:bottom"><p>50 to 100</p></td></tr><tr><td style="vertical-align:top"><p><strong>Central Neural Blocks</strong></p></td><td style="vertical-align:bottom"><p>&nbsp;</p></td><td style="vertical-align:bottom"><p>&nbsp;</p></td><td style="vertical-align:bottom"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p>Epidural*</p></td><td style="vertical-align:bottom"><p>&nbsp;</p></td><td style="vertical-align:bottom"><p>&nbsp;</p></td><td style="vertical-align:bottom"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p>Thoracic</p></td><td style="vertical-align:bottom"><p>1</p></td><td style="vertical-align:bottom"><p>20 to 30</p></td><td style="vertical-align:bottom"><p>200 to 300</p></td></tr><tr><td style="vertical-align:top"><p>Lumbar</p></td><td style="vertical-align:bottom"><p>&nbsp;</p></td><td style="vertical-align:bottom"><p>&nbsp;</p></td><td style="vertical-align:bottom"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p>Analgesia</p></td><td style="vertical-align:bottom"><p>1</p></td><td style="vertical-align:bottom"><p>25 to 30</p></td><td style="vertical-align:bottom"><p>250 to 300</p></td></tr><tr><td style="vertical-align:top"><p>Anesthesia</p></td><td style="vertical-align:bottom"><p>1.5</p></td><td style="vertical-align:bottom"><p>15 to 20</p></td><td style="vertical-align:bottom"><p>225 to 300</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:bottom"><p>2</p></td><td style="vertical-align:bottom"><p>10 to 15</p></td><td style="vertical-align:bottom"><p>200 to 300</p></td></tr><tr><td style="vertical-align:top"><p>Caudal</p></td><td style="vertical-align:bottom"><p>&nbsp;</p></td><td style="vertical-align:bottom"><p>&nbsp;</p></td><td style="vertical-align:bottom"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p>Obstetrical analgesia</p></td><td style="vertical-align:bottom"><p>1</p></td><td style="vertical-align:bottom"><p>20 to 30</p></td><td style="vertical-align:bottom"><p>200 to 300</p></td></tr><tr><td style="vertical-align:top"><p>Surgical anesthesia</p></td><td style="vertical-align:bottom"><p>1.5</p></td><td style="vertical-align:bottom"><p>15 to 20</p></td><td style="vertical-align:bottom"><p>225 to 300</p></td></tr></tbody></table><p>*&nbsp; Dose determined by number of dermatomes to be anesthetized (2 to 3 ml/dermatome).</p><p>THE ABOVE SUGGESTED CONCENTRATIONS AND VOLUMES SERVE ONLY AS A GUIDE. OTHER VOLUMES AND CONCENTRATIONS MAY BE USED PROVIDED THE TOTAL MAXIMUM RECOMMENDED DOSE IS NOT EXCEEDED.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Lidocaine HCl is contraindicated in patients with a known history of hypersensitivity to local anesthetics of the amide type.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>WARNINGS</strong></p><p><strong><em>&nbsp;</em></strong></p><p>LIDOCAINE HYDROCHLORIDE INJECTION, FOR INFILTRATION AND NERVE BLOCK, SHOULD BE EMPLOYED ONLY BY CLINICIANS WHO ARE WELL VERSED IN DIAGNOSIS AND MANAGEMENT OF DOSE-RELATED TOXICITY AND OTHER ACUTE EMERGENCIES THAT MIGHT ARISE FROM THE BLOCK TO BE EMPLOYED AND THEN ONLY AFTER ENSURING THE <strong><em>IMMEDIATE</em></strong> AVAILABILITY OF OXYGEN, OTHER RESUSCITATIVE DRUGS, CARDIOPULMONARY EQUIPMENT AND THE PERSONNEL NEEDED FOR PROPER MANAGEMENT OF TOXIC REACTIONS AND RELATED EMERGENCIES (see also section <em>4.8&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Undesirable effects</em>). DELAY IN PROPER MANAGEMENT OF DOSE-RELATED TOXICITY, UNDERVENTILATION FROM ANY CAUSE AND/OR ALTERED SENSITIVITY MAY LEAD TO THE DEVELOPMENT OF ACIDOSIS, CARDIAC ARREST AND, POSSIBLY, DEATH.</p><p><strong>&nbsp;</strong></p><p><strong>Methemoglobinemia</strong></p><p>Cases of methemoglobinemia have been reported in association with local anesthetic use. Although all patients are at risk for methemoglobinemia, patients with glucose-6-phosphate dehydrogenase deficiency, congenital or idiopathic methemoglobinemia, cardiac or pulmonary compromise, infants under 6 months of age, and concurrent exposure to oxidizing agents or their metabolites are more susceptible to developing clinical manifestations of the condition. If local anesthetics must be used in these patients, close monitoring for symptoms and signs of methemoglobinemia is recommended.</p><p>&nbsp;</p><p>Signs of methemoglobinemia may occur immediately or may be delayed some hours after exposure, and are characterized by a cyanotic skin discoloration and/or abnormal coloration of the blood. Methemoglobin levels may continue to rise; therefore, immediate treatment is required to avert more serious central nervous system and cardiovascular adverse effects, including seizures, coma, arrhythmias, and death.</p><p>&nbsp;</p><p>Discontinue lidocaine hydrochloride and any other oxidizing agents. Depending on the severity of the signs and symptoms, patients may respond to supportive care, i.e., oxygen therapy, hydration. A more severe clinical presentation may require treatment with methylene blue, exchange transfusion, or hyperbaric oxygen.</p><p>&nbsp;</p><p>Intra-articular infusions of local anesthetics following arthroscopic and other surgical procedures is an unapproved use, and there have been post-marketing reports of chondrolysis in patients receiving such infusions. The majority of reported cases of chondrolysis have involved the shoulder joint; cases of gleno‑humeral chondrolysis have been described in pediatric and adult patients following intra-articular infusions of local anesthetics with and without epinephrine for periods of 48 to 72 hours. There is insufficient information to determine whether shorter infusion periods are not associated with these findings. The time of onset of symptoms, such as joint pain, stiffness and loss of motion can be variable, but may begin as early as the 2nd month after surgery. Currently, there is no effective treatment for chondrolysis; patients who experienced chondrolysis have required additional diagnostic and therapeutic procedures and some required arthroplasty or shoulder replacement.</p><p>&nbsp;</p><p>To avoid intravascular injection, aspiration should be performed before the local anesthetic solution is injected. The needle must be repositioned until no return of blood can be elicited by aspiration. Note, however, that the absence of blood in the syringe does not guarantee that intravascular injection has been avoided.</p><p>&nbsp;</p><p>Anaphylactic reactions may occur following administration of lidocaine hydrochloride (see section <em>4.8 Undesirable effects</em>).</p><p>In the case of severe reaction, discontinue the use of the drug.</p><p>&nbsp;</p><p><strong>PRECAUTIONS</strong></p><p><strong>&nbsp;</strong></p><p><strong>General</strong></p><p>The safety and effectiveness of lidocaine HCl depend on proper dosage, correct technique, adequate precautions, and readiness for emergencies. Standard textbooks should be consulted for specific techniques and precautions for various regional anesthetic procedures.</p><p>Resuscitative equipment, oxygen, and other resuscitative drugs should be available for immediate use (see <em>4.8 Undesirable effects</em>). The lowest dosage that results in effective anesthesia should be used to avoid high plasma levels and serious adverse effects. Syringe aspirations should also be performed before and during each supplemental injection when using indwelling catheter techniques. During the administration of epidural anesthesia, it is recommended that a test dose be administered initially and that the patient be monitored for central nervous system toxicity and cardiovascular toxicity, as well as for signs of unintended intrathecal administration, before proceeding. When clinical conditions permit, consideration should be given to employing local anesthetic solutions that contain epinephrine for the test dose because circulatory changes compatible with epinephrine may also serve as a warning sign of unintended intravascular injection. An intravascular injection is still possible even if aspirations for blood are negative.</p><p>&nbsp;</p><p>Repeated doses of lidocaine HCl may cause significant increases in blood levels with each repeated dose because of slow accumulation of the drug or its metabolites. Tolerance to elevated blood levels varies with the status of the patient. Debilitated, elderly patients, acutely ill patients, and children should be given reduced doses commensurate with their age and physical condition. Lidocaine HCl should also be used with caution in patients with severe shock or heart block.</p><p>&nbsp;</p><p>Lumbar and caudal epidural anesthesia should be used with extreme caution in persons with the following conditions: existing neurological disease, spinal deformities, septicemia, and severe hypertension.</p><p>&nbsp;</p><p>Local anesthetic solutions containing a vasoconstrictor should be used cautiously and in carefully circumscribed quantities in areas of the body supplied by end arteries or having otherwise compromised blood supply. Patients with peripheral vascular disease and those with hypertensive vascular disease may exhibit exaggerated vasoconstrictor response. Ischemic injury or necrosis may result. Preparations containing a vasoconstrictor should be used with caution in patients during or following the administration of potent general anesthetic agents, since cardiac arrhythmias may occur under such conditions.</p><p>&nbsp;</p><p>Careful and constant monitoring of cardiovascular and respiratory (adequacy of ventilation) vital signs and the patient&rsquo;s state of consciousness should be accomplished after each local anesthetic injection. It should be kept in mind at such times that restlessness, anxiety, tinnitus, dizziness, blurred vision, tremors, depression or drowsiness may be early warning signs of central nervous system toxicity.</p><p>&nbsp;</p><p>Since amide-type local anesthetics are metabolized by the liver, lidocaine should be used with caution in patients with hepatic disease. Patients with severe hepatic disease, because of their inability to metabolize local anesthetics normally, are at greater risk of developing toxic plasma concentrations. Lidocaine should also be used with caution in patients with impaired cardiovascular function since they may be less able to compensate for functional changes associated with the prolongation of A-V conduction produced by these drugs.</p><p>&nbsp;</p><p>Many drugs used during the conduct of anesthesia are considered potential triggering agents for familial malignant hyperthermia. Since it is not known whether amide-type local anesthetics may trigger this reaction and since the need for supplemental general anesthesia cannot be predicted in advance, it is suggested that a standard protocol for the management of malignant hyperthermia should be available. Early unexplained signs of tachycardia, tachypnea, labile blood pressure and metabolic acidosis may precede temperature elevation. Successful outcome is dependent on early diagnosis, prompt discontinuance of the suspect triggering agent(s) and institution of treatment, including oxygen therapy, indicated supportive measures and dantrolene (consult dantrolene sodium intravenous package insert before using).</p><p>&nbsp;</p><p>Proper tourniquet technique, as described in publications and standard textbooks, is essential in the performance of intravenous regional anesthesia. Solutions containing epinephrine or other vasoconstrictors should not be used for this technique.</p><p>&nbsp;</p><p>Lidocaine HCl should be used with caution in persons with known drug sensitivities. Patients allergic to para-aminobenzoic acid derivatives (procaine, tetracaine, benzocaine, etc.) have not shown cross‑sensitivity to lidocaine HCl.</p><p><strong>&nbsp;</strong></p><p><strong>Use in the Head and Neck Area</strong></p><p>Small doses of local anesthetics injected into the head and neck area, including retrobulbar, dental and stellate ganglion blocks, may produce adverse reactions similar to systemic toxicity seen with unintentional intravascular injections of larger doses. Confusion, convulsions, respiratory depression and/or respiratory arrest, and cardiovascular stimulation or depression have been reported. These reactions may be due to intra-arterial injections of the local anesthetic with retrograde flow to the cerebral circulation. Patients receiving these blocks should have their circulation and respiration monitored and be constantly observed. Resuscitative equipment and personnel for treating adverse reactions should be immediately available. Dosage recommendations should not be exceeded (see section <em>4.2&nbsp;&nbsp;&nbsp;&nbsp; Posology and method of administration</em>).</p><p>&nbsp;</p><p><strong>Information for Patients</strong></p><p>When appropriate, patients should be informed in advance that they may experience temporary loss of sensation and motor activity, usually in the lower half of the body, following proper administration of epidural anesthesia.</p><p>&nbsp;</p><p>Inform patients that use of local anesthetics may cause methemoglobinemia, a serious condition that must be treated promptly. Advise patients or caregivers to seek immediate medical attention if they or someone in their care experience the following signs or symptoms: pale, gray, or blue colored skin (cyanosis); headache; rapid heart rate; shortness of breath; lightheadedness; or fatigue.</p><p>&nbsp;</p><p><strong>Pediatric Use</strong></p><p>Dosages in children should be reduced, commensurate with age, body weight and physical condition (see section <em>4.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Posology and method of administration</em>).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Clinically Significant Drug </strong><strong>Interactions</strong></p><p>The administration of local anesthetic solutions containing epinephrine or norepinephrine to patients receiving monoamine oxidase inhibitors or tricyclic anti-depressants may produce severe, prolonged hypertension.</p><p>&nbsp;</p><p>Phenothiazines and butyrophenones may reduce or reverse the pressor effect of epinephrine.</p><p>&nbsp;</p><p>Concurrent use of these agents should generally be avoided. In situations when concurrent therapy is necessary, careful patient monitoring is essential.</p><p>&nbsp;</p><p>Concurrent administration of vasopressor drugs (for the treatment of hypotension related to obstetric blocks) and ergot-type oxytocic drugs may cause severe, persistent hypertension or cerebrovascular accidents.</p><p><strong>&nbsp;</strong></p><p><strong>Drug/Laboratory Test Interactions</strong></p><p>The intramuscular injection of lidocaine HCl may result in an increase in creatine phosphokinase levels. Thus, the use of this enzyme determination, without isoenzyme separation, as a diagnostic test for the presence of acute myocardial infarction may be compromised by the intramuscular injection of lidocaine HCl.</p><p>&nbsp;</p><p>Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics:</p><p>&nbsp;</p><p>Examples of Drugs Associated with Methemoglobinemia:</p><p><strong>&nbsp;</strong></p><table border="0" cellspacing="0" cellpadding="0" style="width:94%"><tbody><tr><td><p><strong>Class</strong></p></td><td><p><strong>Examples</strong></p></td></tr><tr><td><p>Nitrates/Nitrites</p></td><td><p>nitric oxide, nitroglycerin, nitroprusside, nitrous oxide</p></td></tr><tr><td><p>Local anesthetics</p></td><td><p>articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine</p></td></tr><tr><td><p>Antineoplastic agents</p></td><td><p>cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase</p></td></tr><tr><td><p>Antibiotics</p></td><td><p>dapsone, nitrofurantoin, para‑aminosalicylic acid, sulfonamides</p></td></tr><tr><td><p>Antimalarials</p></td><td><p>chloroquine, primaquine</p></td></tr><tr><td><p>Anticonvulsants</p></td><td><p>phenobarbital, phenytoin, sodium valproate</p></td></tr><tr><td><p>Other drugs</p></td><td><p>acetaminophen, metoclopramide, quinine, sulfasalazine</p></td></tr></tbody></table>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Carcinogenesis, Mutagenesis, Impairment of Fertility</u></p><p>Studies of lidocaine HCl in animals to evaluate the carcinogenic and mutagenic potential or the effect on fertility have not been conducted.</p><p><strong>&nbsp;</strong></p><p><u>Pregnancy</u></p><p>Teratogenic Effects</p><p>Reproduction studies have been performed in rats at doses up to 6.6 times the human dose and have revealed no evidence of harm to the fetus caused by lidocaine HCl. There are, however, no adequate and well-controlled studies in pregnant women. Animal reproduction studies are not always predictive of human response. General consideration should be given to this fact before administering lidocaine HCl to women of childbearing potential, especially during early pregnancy when maximum organogenesis takes place.</p><p>&nbsp;</p><p><u>Breast-feeding</u></p><p>It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when lidocaine HCl is administered to a nursing woman.</p><p>&nbsp;</p><p><u>Labor and Delivery</u></p><p>Local anesthetics rapidly cross the placenta and when used for epidural, paracervical, pudendal or caudal block anesthesia, can cause varying degrees of maternal, fetal and neonatal toxicity (see section <em>5. PHARMACOLOGICAL PROPERTIES</em>). The potential for toxicity depends upon the procedure performed, the type and amount of drug used, and the technique of drug administration. Adverse reactions in the parturient, fetus and neonate involve alterations of the central nervous system, peripheral vascular tone and cardiac function.</p><p>&nbsp;</p><p>Maternal hypotension has resulted from regional anesthesia. Local anesthetics produce vasodilation by blocking sympathetic nerves. Elevating the patient&rsquo;s legs and positioning her on her left side will help prevent decreases in blood pressure.</p><p>&nbsp;</p><p>The fetal heart rate also should be monitored continuously, and electronic fetal monitoring is highly advisable.</p><p>&nbsp;</p><p>Epidural, spinal, paracervical, or pudendal anesthesia may alter the forces of parturition through changes in uterine contractility or maternal expulsive efforts. In one study, paracervical block anesthesia was associated with a decrease in the mean duration of first stage labor and facilitation of cervical dilation. However, spinal and epidural anesthesia have also been reported to prolong the second stage of labor by removing the parturient&rsquo;s reflex urge to bear down or by interfering with motor function. The use of obstetrical anesthesia may increase the need for forceps assistance.</p><p>&nbsp;</p><p>The use of some local anesthetic drug products during labor and delivery may be followed by diminished muscle strength and tone for the first day or two of life. The long-term significance of these observations is unknown. Fetal bradycardia may occur in 20 to 30 percent of patients receiving paracervical nerve block anesthesia with the amide-type local anesthetics and may be associated with fetal acidosis. Fetal heart rate should always be monitored during paracervical anesthesia. The physician should weigh the possible advantages against risks when considering a paracervical block in prematurity, toxemia of pregnancy, and fetal distress. Careful adherence to recommended dosage is of the utmost importance in obstetrical paracervical block. Failure to achieve adequate analgesia with recommended doses should arouse suspicion of intravascular or fetal intracranial injection. Cases compatible with unintended fetal intracranial injection of local anesthetic solution have been reported following intended paracervical or pudendal block or both. Babies so affected present with unexplained neonatal depression at birth, which correlates with high local anesthetic serum levels, and often manifest seizures within six hours. Prompt use of supportive measures combined with forced urinary excretion of the local anesthetic has been used successfully to manage this complication.</p><p>&nbsp;</p><p>Case reports of maternal convulsions and cardiovascular collapse following use of some local anesthetics for paracervical block in early pregnancy (as anesthesia for elective abortion) suggest that systemic absorption under these circumstances may be rapid. The recommended maximum dose of each drug should not be exceeded. Injection should be made slowly and with frequent aspiration. Allow a 5‑minute interval between sides.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not available.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Systemic</strong></p><p>Adverse experiences following the administration of lidocaine HCl are similar in nature to those observed with other amide local anesthetic agents. These adverse experiences are, in general, dose-related and may result from high plasma levels caused by excessive dosage, rapid absorption or inadvertent intravascular injection, or may result from a hypersensitivity, idiosyncrasy or diminished tolerance on the part of the patient. Serious adverse experiences are generally systemic in nature. The following types are those most commonly reported:</p><p>&nbsp;</p><p><strong>Central Nervous System</strong></p><p>CNS manifestations are excitatory and/or depressant and may be characterized by lightheadedness, nervousness, apprehension, euphoria, confusion, dizziness, drowsiness, tinnitus, blurred or double vision, vomiting, sensations of heat, cold or numbness, twitching, tremors, convulsions, unconsciousness, respiratory depression and arrest. The excitatory manifestations may be very brief or may not occur at all, in which case the first manifestation of toxicity may be drowsiness merging into unconsciousness and respiratory arrest.</p><p>&nbsp;</p><p>Drowsiness following the administration of lidocaine HCl is usually an early sign of a high blood level of the drug and may occur as a consequence of rapid absorption.</p><p>&nbsp;</p><p><strong>Cardiovascular System</strong></p><p>Cardiovascular manifestations are usually depressant and are characterized by bradycardia, hypotension, and cardiovascular collapse, which may lead to cardiac arrest.</p><p>&nbsp;</p><p><strong>Allergic</strong></p><p>Allergic reactions are characterized by cutaneous lesions, urticaria, edema or anaphylactoid reactions. Allergic reactions may occur as a result of sensitivity either to local anesthetic agents. Allergic reactions, including anaphylactic reactions, may occur as a result of sensitivity to lidocaine, but are infrequent. If allergic reactions do occur, they should be managed by conventional means. The detection of sensitivity by skin testing is of doubtful value.</p><p>&nbsp;</p><p>There have been no reports of cross sensitivity between lidocaine hydrochloride and procainamide or between lidocaine hydrochloride and quinidine.</p><p>&nbsp;</p><p><strong>Neurologic</strong></p><p>The incidences of adverse reactions associated with the use of local anesthetics may be related to the total dose of local anesthetic administered and are also dependent upon the particular drug used, the route of administration and the physical status of the patient. In a prospective review of 10,440 patients who received lidocaine HCl for spinal anesthesia, the incidences of adverse reactions were reported to be about 3 percent each for positional headaches, hypotension and backache; 2 percent for shivering; and less than 1 percent each for peripheral nerve symptoms, nausea, respiratory inadequacy and double vision. Many of these observations may be related to local anesthetic techniques, with or without a contribution from the local anesthetic.</p><p>&nbsp;</p><p>In the practice of caudal or lumbar epidural block, occasional unintentional penetration of the subarachnoid space by the catheter may occur. Subsequent adverse effects may depend partially on the amount of drug administered subdurally. These may include spinal block of varying magnitude (including total spinal block), hypotension secondary to spinal block, loss of bladder and bowel control, and loss of perineal sensation and sexual function. Persistent motor, sensory and/or autonomic (sphincter control) deficit of some lower spinal segments with slow recovery (several months) or incomplete recovery have been reported in rare instances when caudal or lumbar epidural block has been attempted. Backache and headache have also been noted following use of these anesthetic procedures.</p><p>&nbsp;</p><p>There have been reported cases of permanent injury to extraocular muscles requiring surgical repair following retrobulbar administration.</p><p>&nbsp;</p><p><strong>Hematologic</strong></p><p>Methemoglobinemia.</p><p><u>&nbsp;</u></p><p><u>Reporting of suspected adverse reactions</u></p><p>Reporting suspected adverse reactions after <u>marketing</u> authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions <u>according to their local country requirements</u>.</p><p><strong>&nbsp;</strong></p><p><strong>To Report side effects</strong></p><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Saudi Arabia</strong></p><p>&nbsp;</p><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>National Pharmacovigilance Centre (NPC)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; SFDA Call Center: 19999</p><ul><li>E-mail: npc.drug@sfda.gov.sa</li><li>Website: https://ade.sfda.gov.sa/&nbsp;&nbsp;</li></ul></td></tr></tbody></table><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Other GCC States</strong></p><p><strong>&nbsp;</strong></p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>Please contact the relevant competent authority.</p></td></tr></tbody></table>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Acute emergencies from local anesthetics are generally related to high plasma levels encountered during therapeutic use of local anesthetics or to unintended subarachnoid injection of local anesthetic solution (see section <em>4.4 Special warnings and precautions for use </em>and<em> </em><em>4.8 Undesirable effects</em>).</p><p><strong>&nbsp;</strong></p><p><strong>Management of Local Anesthetic Emergencies</strong></p><p>The first consideration is prevention, best accomplished by careful and constant monitoring of cardiovascular and respiratory vital signs and the patient&rsquo;s state of consciousness after each local anesthetic injection. At the first sign of change, oxygen should be administered.</p><p>&nbsp;</p><p>The first step in the management of convulsions, as well as underventilation or apnea due to unintended subarachnoid injection of drug solution, consists of immediate attention to the maintenance of a patent airway and assisted or controlled ventilation with oxygen and a delivery system capable of permitting immediate positive airway pressure by mask. Immediately after the institution of these ventilatory measures, the adequacy of the circulation should be evaluated, keeping in mind that drugs used to treat convulsions sometimes depress the circulation when administered intravenously. Should convulsions persist despite adequate respiratory support, and if the status of the circulation permits, small increments of an ultra-short acting barbiturate (such as thiopental or thiamylal) or a benzodiazepine (such as diazepam) may be administered intravenously. The clinician should be familiar, prior to the use of local anesthetics, with these anticonvulsant drugs. Supportive treatment of circulatory depression may require administration of intravenous fluids and, when appropriate, a vasopressor as directed by the clinical situation (e.g., ephedrine).</p><p>&nbsp;</p><p>If not treated immediately, both convulsions and cardiovascular depression can result in hypoxia, acidosis, bradycardia, arrhythmias and cardiac arrest. Underventilation or apnea due to unintentional subarachnoid injection of local anesthetic solution may produce these same signs and also lead to cardiac arrest if ventilatory support is not instituted. If cardiac arrest should occur, standard cardiopulmonary resuscitative measures should be instituted.</p><p>&nbsp;</p><p>Endotracheal intubation, employing drugs and techniques familiar to the clinician, may be indicated, after initial administration of oxygen by mask, if difficulty is encountered in the maintenance of a patent airway or if prolonged ventilatory support (assisted or controlled) is indicated.</p><p>&nbsp;</p><p>Dialysis is of negligible value in the treatment of acute overdosage with lidocaine HCl.</p><p>&nbsp;</p><p>The oral LD<sub>50</sub> of lidocaine HCl in non-fasted female rats is 459 (346 to 773) mg/kg (as the salt) and 214&nbsp;(159 to 324) mg/kg (as the salt) in fasted female rats.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>ATC code: N01BB02</p><p><u>&nbsp;</u></p><p><u>Mechanism of Action</u></p><p>Lidocaine HCl stabilizes the neuronal membrane by inhibiting the ionic fluxes required for the initiation and conduction of impulses thereby effecting local anesthetic action.</p><p>&nbsp;</p><p><u>Hemodynamics</u></p><p>Excessive blood levels may cause changes in cardiac output, total peripheral resistance, and mean arterial pressure. With central neural blockade these changes may be attributable to block of autonomic fibers, a direct depressant effect of the local anesthetic agent on various components of the cardiovascular system, and/or the beta-adrenergic receptor stimulating action of epinephrine when present. The net effect is normally a modest hypotension when the recommended dosages are not exceeded.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Information derived from diverse formulations, concentrations and usages reveals that lidocaine HCl is completely absorbed following parenteral administration, its rate of absorption depending, for example, upon various factors such as the site of administration and the presence or absence of a vasoconstrictor agent. Except for intravascular administration, the highest blood levels are obtained following intercostal nerve block and the lowest after subcutaneous administration.</p><p>&nbsp;</p><p>The plasma binding of lidocaine HCl is dependent on drug concentration, and the fraction bound decreases with increasing concentration. At concentrations of 1 to 4 mcg of free base per ml 60 to 80&nbsp;percent of lidocaine HCl is protein bound. Binding is also dependent on the plasma concentration of the alpha-1-acid glycoprotein.</p><p>&nbsp;</p><p>Lidocaine HCl crosses the blood-brain and placental barriers, presumably by passive diffusion.</p><p>&nbsp;</p><p>Lidocaine HCl is metabolized rapidly by the liver, and metabolites and unchanged drug are excreted by the kidneys. Biotransformation includes oxidative N-dealkylation, ring hydroxylation, cleavage of the amide linkage, and conjugation. N-dealkylation, a major pathway of biotransformation, yields the metabolites monoethylglycinexylidide and glycinexylidide. The pharmacological/toxicological actions of these metabolites are similar to, but less potent than, those of lidocaine HCl. Approximately 90% of lidocaine HCl administered is excreted in the form of various metabolites, and less than 10% is excreted unchanged. The primary metabolite in urine is a conjugate of 4-hydroxy-2,6-dimethylaniline.</p><p>&nbsp;</p><p>The elimination half-life of lidocaine HCl following an intravenous bolus injection is typically 1.5 to 2&nbsp;hours. Because of the rapid rate at which lidocaine HCl is metabolized, any condition that affects liver function may alter lidocaine HCl kinetics. The half-life may be prolonged two-fold or more in patients with liver dysfunction. Renal dysfunction does not affect lidocaine HCl kinetics but may increase the accumulation of metabolites.</p><p>&nbsp;</p><p>Factors such as acidosis and the use of CNS stimulants and depressants affect the CNS levels of lidocaine HCl required to produce overt systemic effects. Objective adverse manifestations become increasingly apparent with increasing venous plasma levels above 6 mcg free base per ml. In the rhesus monkey arterial blood levels of 18 to 21 mcg/ml have been shown to be threshold for convulsive activity.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Sodium chloride</p><p>Water for injections</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Although no specific incompatibilities have been reported the introduction of any additive requires caution. Do not administer unless the solution is clear.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Lidocaine HCl must not be used after the expiry date which is stated on the label and carton after 'EXP'.  Where only a month and year is stated, the expiry date refers to the last day of that month.

Shelf life: 24 months.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Store at 20 to 25&deg;C (68 to 77&deg;F). [see USP Controlled Room Temperature.]</p><p>&nbsp;</p><p>Disinfecting agents containing heavy metals, which cause release of respective ions (mercury, zinc, copper, etc.) should not be used for skin or mucous membrane disinfection as they have been related to incidents of swelling and edema.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Lidocaine Hydrochloride Injection, USP is supplied as 1 Pre-filled syringe containing 50 mg/ 5ml (1%) and 1 pre-filled syringe containing 100mg/5ml (2%)</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>For single-dose pre-filled syring: Discard unused portion.</p><p>&nbsp;</p><p>Single-dose products are preservative-free.</p><p>&nbsp;</p><p>Any unused medicinal product or waste material should be disposed of in accordance with local requirements.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Marketing Authorization Holder:
Hospira Inc, 275 North Field Drive, Lake Forest, IL 60045, United States

Manufacturer:
Hospira Inc, Highway 301 North, Rocky Mount, NC 27801, United States

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                July 2021
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>